Docking, molecular dynamics simulation studies, and structurebased QSAR model on cytochrome P450 2A6 inhibitors

Structural Chemistry

Volumn 23, Issue 2, 2012, Pages 341-350

  Gharaghani, Sajjad ^a   Khayamian, Taghi ^a   Keshavarz, Fatemeh ^a  

^a ISFAHAN UNIVERSITY OF TECHNOLOGY   (Iran)

Author keywords

CYP2A6; Docking; Least squares support vector regression; Molecular dynamics simulation; QSAR

Indexed keywords

EID: 84862667210     PISSN: 10400400     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11224-011-9874-0     Document Type: Article

References (61)

1. Routh HB, Bhowmik KR, Parish JL, Parish LC (1998) Historical aspects of tobacco use and smoking. Clin Dermatol 16:39-544
2. WHO Global Burden of Disease Report 2008 Geneva
3. WHO Report on the Global Tobacco Epidemic, 2008
4. Nicotine: A Powerful Addiction. Centers for Disease Control and Prevention. (http://www.cdc.gov/tobacco/quit/canquit.htm)
5. Henningfield JE, Miyasato K, Jasinki DR (1985) Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine. J Pharmacol Exp Ther 234:1-12
6. Benowitz NL (1988) Drug therapy: pharmacologic aspects of cigarette smoking and nicotine addition. N Engl J Med 319: 1318-1330
7. Zins BJ, Sandborn WJ, Mays DC, Lawson GM, McKinney JA, Tremaine WJ, Mahoney DW, Zinsmeister AR, Hurt RD, Offord KP, Lipsky JJ (1997) Pharmacokinetics of nicotine tartrate after single-dose liquid enema, oral, and intravenous administration. J Clin Pharmacol 37:426-436
8. McMorrow MJ, Foxx RM (1983) Nicotine's role in smoking: An analysis of nicotine regulation. Psychol Bull 93:302-327
9. Russel SH (1987) Nicotine intake and its regulation by smokers. In: Martin WR, Vauhon GR, Iwamoto ET, David L (eds) Advances in behavioral biology: tobacco, smoking and nicotine. Plenum, New York, pp 25-50
10. Nakajima M, Yamamoto T, Nunoya K, Yokoi T, Nagashma K, Inoue K, Funae Y, Shimada N, Kamataki T, Kuroiwa Y (1996) Role of human cytochrome P4502A6 in C-oxidation of nicotine. Drug Metab Dispos 24:1212-1217
11. Messina ES, Tyndale RF, Sellers EM (1997) A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes. J Pharmacol Exp Ther 282:1608-1614
12. Fernandez-Salguero P, Hoffman SM, Cholerton S, Mohrenweiser H, Raunio H, Rauto A, Pelkonen O, Huang JD, Evans WE, Idle JR, Gonzalez FJ (1995) A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A gnes and identification of variant CYP2A6 alleles. Am J Hum Genet 57: 651-660
13. Pianezza ML, Sellers EM, Tyndale RF (1998) Nicotine metabolism defect reduces smoking. Nature 393:750
14. Crespi CL, Penman BW, Leakey JA, Arlotto MP, Stark A, Parkinson A, Turner T, Steimel DT, Rudo K, Davies RL, Langenbach R (1990) Human cytochrome P450IIA3: cDNA sequence, role of the enzyme in the metabolic activation of promutagens, comparison to nitrosamine activation by human cytochrome P450IIE1. Carcinogenesis 11:1293-1300
15. Yamazaki H, Inui Y, Yun CH, Guengerich FP, Shimada T (1992) Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco related nitrosamines in human liver microsomes. Carcinogenesis 13:1789-1794
16. Visoni S, Meireles N, Monteiro L, Rossini A, Pinto LFR (2008) Different modes of inhibition of mouse Cyp2a5 and rat CYP2A3 by the food-derived 8-methoxypsoralen. Food Chem Toxicol 46:1190-1195
17. Korhonen LE, Rahnasto M, Mähönen NJ, Wittekindt C, Poso A, Juvonen RO, Raunio H (2005) Predictive three-dimensional quantitative structure-activity relationship of cytochrome P450 1A2 inhibitors. J Med Chem 48:3808-3815
18. Sun H, Scott DO (2010) Structure-based drug metabolism predictions for drug design. Chem Biol Drug Des 75:3-17
19. de Groot MJ, Ekins S (2002) Pharmacophore modeling of cytochromes P450. Adv Drug Deliv Rev 54:367-383
20. Poso A, Gynther J, Juvonen R (2001) A comparative molecular field analysis of cytochrome P450 2A5 and 2A6 inhibitors. J Comput Aided Mol Des 15:195-202
21. Wang Y, Li Y, Wang B (2007) An in silico method for screening nicotine derivatives as cytochrome P450 2A6 selective inhibitors based on kernel partial least squares. Int J Mol Sci 8:166-179
22. Damme SV, Bultinck P (2008) Conceptual DFT properties-based 3D QSAR: Analysis of inhibitors of the nicotine metabolizing CYP2A6 enzyme. J Comput Chem 30:1749-1757
23. Leong MK, Chen YM, Chen HB, Chen PH (2009) Development of a new predictive model for interactions with human cytochrome P450 2A6 using pharmacophore ensemble/support vector machine (PhE/SVM) approach. Pharm Res 26:987-1000
24. Rahnasto M, Raunio H, Poso A, Wittekindt C, Juvonen RO (2005) Quantitative structure-activity relationship analysis of inhibitors of the nicotine metabolizing CYP2A6 enzyme. J Med Chem 48:440-449
25. Roy K, Roy PP (2009) Exploring QSAR and QAAR for inhibitors of cytochrome P450 2A6 and 2A5 enzymes using GFA and G/PLS techniques. Eur J Med Chem 44:1941-1951
26. HyperChem, Release 7.0 for windows, Hypercube, Inc., 2002
27. Yano JK, Hsu MH, Griffin KJ, Stout CD, Johnson EF (2005) Structures of human microsomal cytochrome P450 2A6 complexed with coumarin and methoxsalen. Nat Struct Mol Biol 12:822-823
28. Berendsen HJC, van der Spoel D, van Drunen R (1995) GROMACS: A message-passing parallel molecular dynamics implementation. Comput Phys Commun 91:43-56
29. Lindahl E, Hess B, van der Spoel D (2001) GROMACS 3.0: A package for molecular simulation and trajectory analysis. J Mol Model 7:306-317
30. van der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJC (2005) GROMACS: fast, flexible and free. J Comput Chem 26:1701-1719
31. Zhu Q, Vaughn MW (2005) Surface tension effect on transmembrane channel stability in a model membrane. J Phys Chem B 109:19474-19483
32. van Gunsteren WF, Billeter SR, Eising AA, Hüenberger PH, Krüger P, Mark AE, Scott WRP, Tironi IG (1996) Biomolecular simulation: the GROMOS 96 manual and user guide, Switzerland
33. Darden T, York D, Pedersen L (1993) Particle mesh Ewald-an NlogN method for Ewald sums in large systems J. Chem Phys 98:10089-10092
34. Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, Pedersen LG (1995) A smooth particle mesh Ewald method. J Chem Phys 103:8577-8593
35. Swope WC, Andersen HC, Berens PH, Wilson KR (1982) A computer simulation method for the calculation of equilibrium constants for the formation of physical clusters of molecules: Application to small water clusters. J Chem Phys 76:637-649
36. Kennard EH (1963) Kinetic theory of gases. McGraw-Hill, New York, p 77
37. Huang K (1963) Statistical mechanics. Wiley, New York
38. Berendsen HJC, Postma JPM, Van Gunstetren WF, Hermans J (1981) Interaction models for water in relation to protein hydration. In: Pullman B (ed) Intermolecular forces. Reidel, Dordrecht, The Netherlands, pp 331-342
39. Andersen HC (1980) Molecular dynamics simulations at constant pressure and/or temperature. J Chem Phys 72:2384-2393
40. Berendsen HJC, Postma JPM, Van Gunsteren WF, DiNola A, Haak JR (1984) Molecular dynamics with coupling to an external bath. J Chem Phys 81:3684-3690
41. Thompson MA (2004) ArgusLab 4.0.1. Planaria Software LLC, Seatle
42. Schuttelkopf AW, Van Aalten DMF (2004) PRODRG: A tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr D Biol Crystallogr 60:1355-1363
43. www.talete.mi.it
44. Cortes C, Vapnik V (1995) Support vector networks. Mach Learn 20:273-297
45. Suykens JAK, Gestel JAK, Brabanter JD, Moor BD, Vandewalle J (2002) Least squares support vector machines. World Scientifics, Singapore
46. Niazi A, Sharifi S, Amjadi E (2008) Least-squares support vector machines for simultaneous voltammetric determination of lead and tin: A comparison between LS-SVM and PLS in voltammetric data. J Electroanal Chem 623:86-92
47. Sridhar J, Jin P, Liu J, Foroozesh M, ChLK Stevens (2010) In silico studies of polyaromatic hydrocarbon inhibitors of cytochrome P450 enzymes 1A1, 1A2, 2A6, and 2B1. Chem Res Toxicol 23:600-607
48. Hunter CA, Singh J, Thornton JM (1991) Pi-pi interactions: the geometry and energetics of phenylalanine-phenylalanine interactions in proteins. J Mol Biol 218:837-846
49. Salt DW, Ajmani S, Crichton R, Livingstone DJ (2007) An improved approximation to the estimation of the critical F values in best subset regression. J Chem Inf Model 47:143-149
50. Fatemi MH, Gharaghani S (2007) A novel QSAR model for prediction of apoptosis-inducing activity of 4-aryl-4-H-chromenes based on support vector machine. Bioorg Med Chem 15: 7746-7754
51. Todeschini R, Consonni V (2000) Handbook of molecular descriptors. Wiley-VCH, Weinheim, Germany
52. Balaban AT (1982) Highly discriminating distance-based topological index. Chem Phys Lett 89:399-404
53. Bonchev D (1983) Information theoretic indices for characterization of chemical structures. RSP-Wiley, Chichester
54. Consonni V, Todeschini R, Pavan M (2002) Structure/response correlations and similarity/diversity analysis by GETAWAY descriptors. 1. Theory of the novel 3D molecular descriptors. J Chem Inf Comput Sci 42:682-692
55. Consonni V, Todeschini R, Pavan M (2002) Structure/response correlations and similarity/diversity analysis by GETAWAY descriptors. 2. Application of the novel 3D molecular descriptors to QSAR/QSPR studies. J Chem Inf Comput Sci 42:693-705
56. Hemmer MC, Steinhauer V, Gasteiger J (1999) Deriving the 3D structure of organic molecules from their infrared spectra. Vib Spectrosc 19:151-164
57. Palm K, Luthman K, Ungell AL, Strandlund G, Beigi F, Lundahl P, Artursson P (1998) Evaluation of dynamic polar molecular surface area as predictor of drug absorption: comparison with other computational and experimental predictors. J Med Chem 41:5382-5392
58. Winiwarter S, Bonham NM, Ax F, Hallberg A, Lennernas H, KarlCn A (1998) Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach. J Med Chem 41:4939-4949
59. Ensafi AA, Hasanpour F, Khayamian T (2009) Simultaneous chemiluminescence determination of promazine and fluphenazine using support vector regression. Talanta 79:534-538
60. Tropsha A, Gramatica P, Gombar VK (2003) The importance of being earnest: validation is the absolute essential for successful application and interpretation of QSPR models. QSAR Comb Sci 22:69-77
61. Puzyn T, Mostrag-Szlichtyng A, Gajewicz A, Skrzyński M, Worth AP (2011) Investigating the influence of data splitting on the predictive ability of QSAR/QSPR models. Struct Chem 22: 795-804